Comment
doi: 10.1097/AOG.0000000000003912.
In Reply
Affiliations
- PMID: 32443071
- DOI: 10.1097/AOG.0000000000003912
Item in Clipboard
Comment
In Reply
Obstet Gynecol.
2020 Jun.
No abstract available
Comment on
-
Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.Obstet Gynecol. 2020 Feb;135(2):319-327. doi: 10.1097/AOG.0000000000003656. Obstet Gynecol. 2020. PMID: 31923062 Free PMC article.
-
Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.Obstet Gynecol. 2020 Jun;135(6):1486-1487. doi: 10.1097/AOG.0000000000003911. Obstet Gynecol. 2020. PMID: 32443070 No abstract available.
Similar articles
-
Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.Obstet Gynecol. 2020 Jun;135(6):1486-1487. doi: 10.1097/AOG.0000000000003911. Obstet Gynecol. 2020. PMID: 32443070 No abstract available.
-
Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.J Tongji Med Univ. 1993;13(2):126-8. doi: 10.1007/BF02887929. J Tongji Med Univ. 1993. PMID: 8230357
-
Cervical carcinogenesis and contraception.Diagn Cytopathol. 1991;7(4):346-52. doi: 10.1002/dc.2840070405. Diagn Cytopathol. 1991. PMID: 1935511
-
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006. Drug Saf. 1996. PMID: 8968696 Review.
-
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review.
References
REFERENCE
-
- Spotnitz ME, Natarajan K, Ryan PB, Westhoff CL. Relative risk of cervical neoplasms among copper and levonorgestrel-releasing intrauterine system users. Obstet Gynecol 2020;135:319–27.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
